Skip to content

    Ginkgo Bioworks Holdings (DNA) stock price & financials

    View DNA earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance43.6% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $89.05M
    $43.85M
    $38.23M
    $39.13M
    $38.84M
    -56.4%
    $53.95M
    +23.1%
    $19.47M
    -49.1%
    $20.16M
    -48.5%
    Weakening
    Operating Profit
    -$55.20M
    -$103.61M
    -$80.97M
    -$58.16M
    -$90.02M
    -63.1%
    -$86.13M
    +16.9%
    -$71.37M
    +11.9%
    -$58.55M
    -0.7%
    Strengthening
    Net Profit
    -$56.40M
    -$90.96M
    -$60.30M
    -$80.75M
    -43.2%
    -$80.75M
    -$82.59M
    +9.2%
    -$46.71M
    +22.5%
    Strengthening
    EPS
    $-1.08
    $-1.68
    $-1.10
    $-1.45
    -34.3%
    $-1.39
    +17.3%
    $-0.75
    +31.8%
    Strengthening
    Other Income
    Interest
    -$9.25M
    Depreciation
    Profit before Tax
    -$56.78M
    -$107.86M
    -$83.22M
    -$53.48M
    -$80.75M
    -42.2%
    -$96.15M
    +10.9%
    -$76.14M
    +8.5%
    -$57.19M
    -6.9%
    Strengthening
    MarginsOPM
    -62.0%
    -236.3%
    -211.8%
    -148.6%
    -231.8%
    -273.9%
    -159.6%
    +32.4%
    -366.5%
    -73.0%
    -290.5%
    -95.4%
    Weakening
    Tax
    0.7%
    0.3%
    -0.1%
    0.5%
    0.0%
    -100.0%
    0.7%
    +123.3%
    0.1%
    -0.2%
    -141.5%
    Weakening
    ReturnsROIC
    0.9%
    1.4%
    1.0%
    1.3%
    +43.2%
    1.3%
    1.3%
    -9.2%
    0.7%
    -22.5%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$495.29M$380.80M$1.55B$1.32B$944.07M$561.57M$167.20M$84.53M
    Short-Term Investments$0$255.42M
    Total Current Assets$426.54M$1.72B$1.45B$1.00B$602.74M$471.84M$332.54M
    Net PP&E$121.44M$145.77M$715.53M$394.99M$598.15M$528.29M$504.85M
    Goodwill$1.86M$1.86M$21.31M$60.21M$49.24M$0
    Intangibles$3.29M$21.64M$111.04M$82.74M$72.51M$53.48M$44.39M
    Total Assets$675.15M$2.07B$2.54B$1.67B$1.38B$1.12B$990.05M
    LiabilitiesTotal Current Liabilities$73.22M$134.76M$172.96M$163.86M$107.27M$95.97M$72.74M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$0$413.26M$221.84M$438.77M$417.08M$404.11M
    Total Liabilities$205.10M$503.61M$803.04M$568.19M$661.39M$611.11M$569.76M
    EquityCommon Stock & APIC$129.0K$161.0K$190.0K$5.0K$5.0K$6.0K$6.0K
    Retained Earnings-$467.88M-$2.30B-$4.40B-$5.29B-$5.84B-$6.15B-$6.28B
    Total Equity$501.85M$461.38M$1.51B$1.74B$1.10B$716.06M$508.59M$420.28M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$44.66M-$135.83M-$253.82M-$252.20M-$295.50M-$319.58M-$171.06M-$170.24M
    Cash from Investing-$74.60M-$67.12M-$73.26M-$67.39M-$80.69M-$62.24M-$240.29M$56.50M
    Cash from Financing$410.38M$90.32M$1.53B$95.34M-$3.22M-$1.74M$17.77M$34.55M
    SummaryCapital Expenditure-$22.22M-$57.82M-$56.52M-$52.27M-$40.80M-$62.54M-$7.67M-$4.56M
    Free Cash Flow-$66.88M-$193.65M-$310.34M-$304.47M-$336.30M-$382.13M-$178.72M-$174.80M
    FCF Margin-123.4%-252.6%-98.9%-63.7%-133.7%-168.3%-105.0%-132.0%

    Ratios